PubMed Health⌕ Search

PubMed · 2419857

Design-dependent cross-talk in a second generation DDD pacemaker.

Abstract

A unique mechanism of "cross-talk" has recently been described in the Gemini 415A DDD pacemaker in which cross-inhibition of the ventricular output stimulus may occur in the early Gemini 415A models which were manufactured with dual anodal rings interconnected by a wire. The Gemini 415A units with dual anodal rings were implanted under investigational protocol in 53 patients from September 1982 to August 1984. To date, cross-talk has been discovered in six patients during clinical follow-up, manifesting as inappropriate ventricular inhibition. Syncope was documented in one patient. Non-Cordis atrial and ventricular leads were present in all six patients and five patients had at least one chronic lead. Cross-talk was neither evident nor provokable in Gemini 415A units which had compatible Cordis lead systems. Reduction of the atrial output and/or the ventricular sensitivity prevented cross-inhibition in three patients. Cross-talk persisted in three patients despite programming to the lowest atrial output and/or ventricular sensitivity parameters. Cross-talk, spontaneous or provoked, has not occurred in 36 patients having currently designed 415A pulse generators manufactured with a single anodal ring in the ventricular connector channel. We conclude that: this unique form of cross-talk is "design-dependent" and occurs only in Gemini 415As with dual interconnected anodal rings and cannot occur in 415As manufactured with a single anodal ring; this form of cross-talk has occurred only in 415As with non-Cordis leads and appears to be a time-dependent development; reduction of the atrial output or use of pacing modes without atrial pacing or ventricular sensing can prevent cross-talk.(ABSTRACT TRUNCATED AT 250 WORDS)

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B B Beaver, J D Maloney, L W Castle, V A Morant, J M Keefe, E Ching. 1986. Design-dependent cross-talk in a second generation DDD pacemaker.. https://doi.org/10.1111/j.1540-8159.1986.tb05362.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Sarcoidosis presenting with tachy- and brady-arrhythmias.

We describe a case report of a 49-year-old man admitted to a cardiology unit with a series of arrhythmias with no initially obvious aetiology. Further assessment and the use of cardiac magnetic resonance imaging and histology allowed a diagnosis of cardiac sarcoidosis to be made. Cardiac sarcoidosis is a major cause of death in patients with systemic sarcoidosis. Cardiac magnetic resonance imaging is an additional diagnostic tool for this condition without ionizing radiation exposure.

Bradycardia↗

Non-sinus bradyarrhythmias in very low birth weight infants.

Transient bradycardias occur frequently in preterm infants with apnea of prematurity. However, occurrence of non-sinus bradyarrhythmias in very low birth weight (VLBW) infants has received very little attention. This case series documents transient bradyarrhythmias in VLBW infants. Most frequently observed arrhythmia was a non-sinus atrial rhythm followed by junctional escape rhythm. Ventricular rhythm with wide QRS complexes occurred rarely. The majority of these episodes occurred in the absence of oxygen desaturation. Increase in vagal tone is presumed to mediate this response.

Bradycardia↗

QT interval correction in patients with cirrhosis.

INTRODUCTION: QT interval prolongation is a common electrophysiological abnormality in patients with cirrhosis. As QT interval varies with the heart rate, many QT correction formulas have been proposed, the Bazett's one being the most criticized because it over-corrects the QT interval and may be misleading. This study focused on the QT-RR relationship in patients with cirrhosis to derive a population-specific QT correction formula. METHODS: One hundred cirrhotic patients of different etiology and severity and 53 healthy controls comparable for age and sex were enrolled. The QT-RR relationship was analyzed in patients by five regression analysis models to derive the population-specific QT-RR equation. The QTc was calculated and compared with those calculated by four common QT correction formulas (Bazett, Fridericia, Framingham, and Hodges). The correlation coefficient QTc-RR was calculated as a measure of the independence of QTc from the original RR interval. RESULTS: In patients the QT-RR relationship was best described by the power equation "QT = 453.65 x RR1/3.02" (R2 = 0.41), similar to the Fridericia's formula. Bazett's formula led to the longest QTc (P < 0.0001), which was still significantly influenced by the RR interval (R = -0.39; P < 0.0001), while the estimated equation led to a QTc value not influenced by RR (R = -0.014). CONCLUSION: Bazett's correction should be avoided in patients with cirrhosis because it still provides a rate-dependent QTc value and might be misleading, particularly when assessing the overall preoperative cardiac risk and the effect of drugs affecting the QT interval. In its place, our formula or that of Fridericia can be confidently employed.

Bradycardia↗